Barbara Schilberg
Managing Director and CEO
United States
51 investmentsBarbara Schilberg is a Managing Director and CEO based in United States. Barbara Schilberg has backed 51 companies, including BioDetego, Hsiri Therapeutics and Mebias Discovery. Investment focus areas include Health Care, Hospitals and Consumer Electronics.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (51)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | BioDetego | — | — | — | — |
| 2 | Hsiri Therapeutics | — | — | — | — |
| 3 | Mebias Discovery | — | — | — | — |
| 4 | Noble.MD | — | — | — | — |
| 5 | Treventis | — | — | — | — |
| 6 | CarePartners Plus | — | — | — | — |
| 7 | Solaris Therapeutics | — | — | — | — |
| 8 | Relmada Therapeutics | — | — | — | — |
| 9 | RMH Sciences | — | — | — | — |
| 10 | Group K Diagnostics | — | — | — | — |
| 11 | Melior Discovery | — | — | — | — |
| 12 | Imiplex | — | — | — | — |
Showing 1–12 of 51
Page 1 of 5
Access Full Contact Information
Get Barbara Schilberg's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required